Eric Warren

Eric Warren (senior executive) discloses dealings in 2 companies, chiefly Esperion Therapeutics, Inc. and Mineralys Therapeutics, Inc. Between 14 March 2022 and 21 September 2026, the trades on record add up to 37 filings.

On the open market, the record shows 1 purchase worth €7,431 and 29 sales worth €581k. Netting one side against the other leaves €573k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants and 3 option exercises. Since January 2026: no purchases and 3 sales on the market.

Most recently, on 22 September 2026, the filings show an option exercise worth €86k in Mineralys Therapeutics, Inc. The last purchase on record was published on 31 August 2022, which is 1,509 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.